Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.

Autor: Sadri E; Visionary Eye Institute, Newport Beach, CA., Paauw JD; Piedmont Eye Center, Lynchburg, VA., Ciolino JB; Department of Ophthalmology, Harvard Medical School, Boston, MA., Nijm L; Warrenville Eye Care and LASIK Center, Warrenville, IL., Simmons B; Vision Institute, Colorado Springs, CO., Meyer J; The Eye Care Institute, Louisville, KY., Gaddie IB; Gaddie Eye Centers, Louisville, KY., Berdy GJ; Ophthalmology Associates, St. Louis, MO., Holdbrook M; Tarsus Pharmaceuticals, Inc, Irvine, CA; and., Baba SN; Tarsus Pharmaceuticals, Inc, Irvine, CA; and., Jalalat P; Visionary Eye Institute, Newport Beach, CA., Yeu E; Virginia Eye Consultants, Norfolk, VA.

Publikováno v: Cornea [Cornea] 2024 Nov 01; Vol. 43 (11), pp. 1368-1374. Date of Electronic Publication: 2024 Feb 09.

The impact of Demodex blepharitis on patient symptoms and daily life.

Autor: Barnett M, Simmons B; Vision Institute, Colorado Springs, Colorado., Vollmer P; Vita Eye Clinic, Shelby, North Carolina., Patel A; Vita Eye Clinic, Shelby, North Carolina., Whitson WE; Whitson Vision, Indianapolis, Indiana., Berdy GJ; Ophthalmology Associates, St. Louis, Missouri., Karpecki P; Kentucky Eye Institute, Lexington, Kentucky., Periman LM; Periman Eye Institute, Seattle, Washington., Holdbrook M; Tarsus Pharmaceuticals Inc., Irvine, California., Baba SN; Tarsus Pharmaceuticals Inc., Irvine, California., Meyer J; The Eye Care Institute, Louisville, Kentucky., Yeu E; Virginia Eye Consultants, Norfolk, Virginia.

Publikováno v: Optometry and vision science : official publication of the American Academy of Optometry [Optom Vis Sci] 2024 Mar 01; Vol. 101 (3), pp. 151-156. Date of Electronic Publication: 2024 Feb 07.

Treatment of Demodex Blepharitis: A Prospective, Randomized, Controlled, Double-Masked Clinical Trial Comparing Topical Lotilaner Ophthalmic Solution, 0.25% Eyedrops to Vehicle.

Autor: Yeu E; Virginia Eye Consultants, Norfolk, Virginia, USA., Holdbrook M; Tarsus Pharmaceuticals, Inc, Irvine, California, USA., Baba SN; Tarsus Pharmaceuticals, Inc, Irvine, California, USA., Ceballos JC; Anterior Segment Surgery Department, Asociación para Evitar la Ceguera en México I.A.P, Mexico City, Mexico., Massaro-Corredor M; Anterior Segment Surgery Department, Asociación para Evitar la Ceguera en México I.A.P, Mexico City, Mexico., Corredor-Ortega C; Anterior Segment Surgery Department, Asociación para Evitar la Ceguera en México I.A.P, Mexico City, Mexico., Ramos-Betancourt N; Cornea Department, Asociación para Evitar la Ceguera en México I.A.P, Mexico City, Mexico., Quiroz-Mercado H; Research Department, Asociación para Evitar la Ceguera en México I.A.P, Mexico City, Mexico., Gonzalez-Salinas R; Anterior Segment Surgery Department, Asociación para Evitar la Ceguera en México I.A.P, Mexico City, Mexico.

Publikováno v: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2023 Oct; Vol. 31 (8), pp. 1653-1661. Date of Electronic Publication: 2022 Aug 01.

Psychosocial Impact of Demodex Blepharitis.

Autor: O'Dell L; Medical Optometry America, Shrewsbury, PA, USA., Dierker DS; Eye Surgeons of Indiana, Indianapolis, IN, USA., Devries DK; Eye Care Associates of Nevada, Sparks, NV, USA., Garlich J; Envision Optometry, Boston, MA, USA., Whitley WO; Virginia Eye Consultants, Norfolk, VA, USA., Holdbrook M; Tarsus Pharmaceuticals, Inc, Irvine, CA, USA., Baba SN; Tarsus Pharmaceuticals, Inc, Irvine, CA, USA., Yeu E; Virginia Eye Consultants, Norfolk, VA, USA.

Publikováno v: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2022 Sep 02; Vol. 16, pp. 2979-2987. Date of Electronic Publication: 2022 Sep 02 (Print Publication: 2022).

Collarette Elimination and Demodex Mite Eradication with Topical Lotilaner Ophthalmic Solution, 0.25.

Autor: Gonzalez-Salinas R; Asociación para Evitar la Ceguera en Mexico I.A.P., Mexico City, Mexico., Yeu E; Virginia Eye Consultants, Norfolk, Virginia, USA., Holdbrook M; Tarsus Pharmaceuticals, Inc., Irvine, California, USA., Baba SN; Tarsus Pharmaceuticals, Inc., Irvine, California, USA., Ceballos JC; Asociación para Evitar la Ceguera en Mexico I.A.P., Mexico City, Mexico., Massaro-Corredor M; Asociación para Evitar la Ceguera en Mexico I.A.P., Mexico City, Mexico., Corredor-Ortega C; Asociación para Evitar la Ceguera en Mexico I.A.P., Mexico City, Mexico., Ramos-Betancourt N; Asociación para Evitar la Ceguera en Mexico I.A.P., Mexico City, Mexico., Quiroz-Mercado H; Asociación para Evitar la Ceguera en Mexico I.A.P., Mexico City, Mexico.

Publikováno v: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2021 Oct; Vol. 37 (8), pp. 479-484. Date of Electronic Publication: 2021 Aug 20.